Elly Kourany-Lefoll

  • Citations Per Year
Learn More
Development of new drugs and vaccines for neglected tropical diseases (NTDs) is unattractive from a market perspective due to the lack of sufficient financial incentives and low return on investment. To address the health burden of NTDs in lowand middle-income countries, research and development (R&D) programs for this group of diseases are increasingly(More)
  • 1